Edit Symbol List
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
pSivida Corp. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 3.0399||$ 5.81|
|Low||$ 2.86||$ 2.37|
The current last sale of $2.87 is 21.10% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a leader in the development of sustained-release drug-delivery products for treating eye diseases. Our products deliver drugs at a controlled and steady rate for months or years. We have developed three of only four sustained-release products approved by the U.S. Food and Drug Administration (FDA) for treatment of back-of-the-eye diseases. The most recent is ILUVIEN® for diabetic macular edema (DME), sold by our licensee in the U.S. and three European Union (EU) countries. Our lead development product, Medidur(TM) for posterior uveitis, is in pivotal phase III clinical trials. Our pre-clinical development program is focused primarily on developing products for chronic ophthalmic diseases utilizing our core technology platforms. ILUVIEN is an injectable, sustained-release micro-insert that provides treatment of DME for three years from a single administration. ILUVIEN is licensed to Alimera Sciences, Inc. ... More ...
Where does PSDV fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$0.21|
|Quarterly EPS Est:||-0.19|